1504pincidence of Chemotherapy-induced Nausea and Vomiting with Moderately Emetogenic Chemotherapy: Advice Study.
نویسندگان
چکیده
Y. Escobar1, G. Cajaraville2, J. Virizuela3, R. Alvarez Alvarez1, A.J. Muñoz Martín4, O. Olariaga2, B. Muros5, M.J. Lecumberri Biurrun6, J. Feliu7, P. Martinez Del Prado8, J.J. Cruz Hernandez9, M.J. Martínez Bautista10, R. Lopez11, A. Blasco12, P. Gascon13, V. Calvo14, P. Luna Fra15, J. Montalar16, P. Del Barrio17, M.V. Tornamira17 Servicio de Oncología Médica, Hospital General Gregorio Marañon, Madrid, SPAIN Servicio de Farmacia, Onkologikoa, San Sebastian, SPAIN Medical Oncology, Hospital Universitario Virgen Macarena, Seville, SPAIN Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Madrid, SPAIN Servicio de Farmacia, Hospital Clínico Virgen de la Victoria de Málaga, Malaga, SPAIN Oncology, Complejo Hospitalario de Navarra, Pamplona, SPAIN Medical Oncology, Hospital Universitario La Paz, Madrid, SPAIN Medical Oncology, Universitary Hospital of Basurto, Bilbao, SPAIN Oncología Médica, Hospital Universitario de Salamanca, Salamanca, SPAIN Servicio de Farmacia, Hospital Universitario Puerta del Mar, Cádiz, SPAIN Oncología Médica, Complejo Hospitalario Universitario de Santiago de Compostela SERGAS, Santiago de Compostela, SPAIN Medical Oncology, Hospital General Universitario de Valencia, Valencia, SPAIN Medical Oncology, Hospital Clinic y Provincial de Barcelona, Barcelona, SPAIN Clinical Oncology, Hospital Universitario Puerta de Hierro Majadahond, Majadahonda, SPAIN Servicio Oncologia, Hospital Universitario Sons Espases, Mallorca, SPAIN Medical Oncology, Hospital Universitari i Polit, Valencia, SPAIN Medical Department, MSD, Madrid, SPAIN
منابع مشابه
Management of chemotherapy induced emesis
Important progress has been achieved in the last few years in the prevention of chemotherapy-induced nausea and vomiting thanks to the introduction in clinical practice first of the 5-HT3 antagonists and of the NK1 antagonists more recently. To prevent acute emesis induced by cisplatin/moderately emetogenic chemotherapy, a combination of aprepitant plus a 5-HT3 antagonist and dexamethasone/a 5-...
متن کاملClinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
BACKGROUND This study was designed to mainly evaluate the activity and safety of olanzapine compared with 5-hydroxytryptamine 3(5-HT3) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly or moderately emetogenic chemotherapy (HEC or MEC). The second goal was to evaluate the impact of olanzapine on quality of life (QoL) of cancer pat...
متن کاملClinical update on palonosetron in the management of chemotherapy-induced nausea and vomiting.
The need to control chemotherapy-induced nausea and vomiting is continuously stimulating research to find better options for the optimal antiemetic care. Palonosetron is different from conventional serotonin receptor antagonists not only by the fact of having a longer half-life but also by higher binding affinity for serotonin receptors. It is the first agent in the class which is approved for ...
متن کاملFosaprepitant and aprepitant: an update of the evidence for their place in the prevention of chemotherapy-induced nausea and vomiting
INTRODUCTION The selective neurokinin-1 receptor antagonist aprepitant is effective in the treatment of acute and delayed chemotherapy-induced nausea and vomiting (CINV) associated with both moderately and highly emetogenic chemotherapy. Fosaprepitant has been developed as an intravenous prodrug of aprepitant. AIMS To update the evidence underlying the use of fosaprepitant to prevent CINV. ...
متن کاملA Prospective Triple-blind Randomized Trial on Safety and Efficacy of Abitant in the Prevention of Chemotherapy-Induced Nausea and Vomiting
Background: Oral Aprepitant, a neurokinin-1 receptor antagonist, is suggested in combination with other antiemetic agents in preventing chemotherapy-induced nausea and vomiting(CINV) associated with emetogenic chemotherapeutic regimens in adolescents, but its efficacy and safety in pediatric patients more than six months are unknown. in this study, we used abitant drug (a generic name of Aprepi...
متن کاملThe Role of Clinical Guidelines for the Management of Chemotherapy-Induced Nausea and Vomiting in Children with Cancer
Background: Nausea and vomiting are among the most important side-effects associated with chemotherapy in children with cancer, affecting the quality of their lives. Clinical guidelines for selecting antiemetics are effective in reducing acute chemotherapy-induced nausea and vomiting (CINV). Materials and Methods: The present quasi-experimental study compared the effectiveness of the Pediatric...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Annals of oncology : official journal of the European Society for Medical Oncology
دوره 25 suppl_4 شماره
صفحات -
تاریخ انتشار 2014